Recent developments in the surgical management of benign prostatic hyperplasia

Area of Science:

• Urology
• Surgical Innovation
• Health Economics

Background:

• Benign prostatic hyperplasia (BPH) presents a significant economic burden.
• Established surgical treatments for BPH, such as open prostatectomy and transurethral resection of the prostate (TURP), are effective but invasive.
• There is a growing need for cost-effective and less morbid BPH management options.

Purpose of the Study:

• To review the evolving landscape of BPH surgical management.
• To compare the efficacy, invasiveness, and cost-effectiveness of traditional and novel BPH treatments.
• To highlight the importance of comparing new modalities against established benchmarks like TURP.

Main Methods:

• Review of established and emerging surgical techniques for BPH.
• Comparison of treatment outcomes including symptom relief, uroflow, morbidity, and retreatment rates.
• Assessment of procedural invasiveness, anesthesia requirements, and hospitalization durations.

Main Results:

• Open prostatectomy offers efficiency but is highly invasive.
• TURP remains a gold standard, with recent improvements reducing morbidity.
• Newer techniques like transurethral electrovaporization of the prostate (TVP), transurethral incision of the prostate (TUIP), laser treatments, transurethral microwave thermotherapy (TUMT), and radiofrequency transurethral needle ablation (TUNA) show promise for reduced invasiveness and complications, though long-term outcomes require further assessment.

Conclusions:

• The surgical management of BPH is advancing with less invasive options.
• Emerging therapies like TVP, TUIP, laser treatments, TUMT, and TUNA offer potential advantages in reduced morbidity and shorter recovery times.
• Cost-effectiveness and long-term efficacy of these newer BPH treatments need continued evaluation to determine their role as alternatives to traditional prostatectomy and medical therapy.